Quantitative F18‐fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign
Matthias Benz(Scripps Health), Fritz C. Eilber(APLA Health), Martin Allen-Auerbach(University of California, Los Angeles), Sarah Dry, Wolfgang Weber(Nuklearmedizinische Klinik des Klinikums rechts der Isar), Michael E. Phelps(National Academy of Engineering), David Elashoff(University of California, Los Angeles), Johannes Czernin(University of California, Los Angeles), William D. Tap(Memorial Sloan Kettering Cancer Center)
Cited by 202
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Quantitation in Positron Emission Computed Tomography
|Journal of Computer Assisted Tomography|1979|1.2k
Positron Emission Tomography in Evaluation of Dementia
|JAMA|2001|952